APA
Click to copy
Pol, S. U., Sveinsson, M., Sudyn, M. L., Babek, N., Siebert, D., Bertolino, N., … Zivadinov, R. (2018). Teriflunomide's Effect on Glia in Experimental Demyelinating Disease: A Neuroimaging and Histologic Study. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging.
Chicago/Turabian
Click to copy
Pol, Suyog U., M. Sveinsson, Michelle L. Sudyn, Natan Babek, Danielle Siebert, N. Bertolino, C. Modica, Marilena Preda, F. Schweser, and R. Zivadinov. “Teriflunomide's Effect on Glia in Experimental Demyelinating Disease: A Neuroimaging and Histologic Study.” Journal of neuroimaging : official journal of the American Society of Neuroimaging (2018).
MLA
Click to copy
Pol, Suyog U., et al. “Teriflunomide's Effect on Glia in Experimental Demyelinating Disease: A Neuroimaging and Histologic Study.” Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging, 2018.
BibTeX Click to copy
@article{suyog2018a,
title = {Teriflunomide's Effect on Glia in Experimental Demyelinating Disease: A Neuroimaging and Histologic Study},
year = {2018},
journal = {Journal of neuroimaging : official journal of the American Society of Neuroimaging},
author = {Pol, Suyog U. and Sveinsson, M. and Sudyn, Michelle L. and Babek, Natan and Siebert, Danielle and Bertolino, N. and Modica, C. and Preda, Marilena and Schweser, F. and Zivadinov, R.}
}
Teriflunomide reduces disability progression and brain atrophy in multiple sclerosis patients. The exact mechanism of action by which teriflunomide exerts these effects is currently unknown. We assessed the effect of teriflunomide on brain glial cells in the Theiler's murine encephalomyelitis virus (TMEV) by using a histological approach in combination with neuroimaging.
